Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in β-cells

Diabetes

Volumn 47, Issue 3, 1998, Pages 365-373

  Mariot, Pascal ^a   Gilon, Patrick ^a   Nenquin, Myriam ^a   Henquin, Jean Claude ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCIUM ION; CYCLIC AMP; DIAZOXIDE; GLIBENCLAMIDE; INSULIN; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM MOBILIZATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DRUG MECHANISM; EXOCYTOSIS; FEMALE; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CYCLIC AMP; DIAZOXIDE; EVOKED POTENTIALS; EXOCYTOSIS; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED STRAINS; PATCH-CLAMP TECHNIQUES; PERFUSION; TOLBUTAMIDE;

EID: 0031913919     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.3.365     Document Type: Article

References (44)

1. Henquin JC: The cell biology of insulin secretion. In The Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir GC, Eds. Philadelphia, Lea and Febiger, 1994, p. 56-80
2. Ashcroft FM, Proks P, Smith PA, Ämmälä C, Bokvist K, Rorsman P: Stimulussecretion coupling in pancreatic βcells. J Cell Biockem 55S:54-65, 1994
3. 2+ and G-proteins. Diabetes Rev 4:276-297, 1996
4. Cook DL, Taborsky G-J: B-cell function and insulin secretion. In Ellenberg and Rijkin's Diabetes Meltitus. 5th ed Porte D, Sherwin RS, Eds. Stamford, CT, Appleton & Lange, 1997, p. 49-73
5. + channels in mouse B-cells, J Clin Invest 89:1288-1295, 1992
6. 2+ influx in rat pancreatic B-cell. Diabetes 41:438-443, 1992
7. + channels in mouse B-cells. J Clin Invest 91:871-880, 1993
8. Groop LC: Sulfonylureas in NIDDM. Diabetes Care 15:737-754, 1992
9. Henquin JC: Established, unsuspected and novel pharmacological insulin secretagogues. In New Antidiabetic Drugs. Bailey CJ, Flatt PR, Eds. London, Smith-Gordon, 1990, p. 93-106
10. Satin LS: New mechanisms for sulfonylurea control of insulin secretion. Endocrine 4:191-198, 1996
11. Panten U, Schwanstecher M, Schwanstecher C: Sulfonylurea receptors and mechanism of sulfonylurea action. Exp Clin Endocrinol 104:1-9, 1996
12. Nelson DA, Aguilar-Bryan L, Raef H, Boyd AK Molecular mechanisms of sulphonylurea action in the pancreatic B-cell. In Nutrient Regulation of Insulin Secretion. Flatt PR, Ed. London, Portland Press, 1992, p. 319-339
13. Ashcroft SJH, Ashcroft FM: The sulfonylurea receptor. Biwhim Biopfiys Ada 1175:45-59, 1992
14. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AK III, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA: Cloning of the βcell highaffinity sulfonylurea receptor: a regulator of insulin secretion. Science 268:423-426, 1995
15. Inagaki N, Gonoi T, Clement JP IV, Namba N, Inazawa J, Gonzalez G, AguilarBryan L, Seino S, Bryan J: Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170, 1995
16. Flatt PR, Shibier O, Szecowka J, Berggren PO: New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic β-cell. Diabete Metab 20:157-162, 1994
17. Eliasson L, Renström E, Äimnälä C, Berggren PO, Bertorello AM, Bokvist K, Chibalin A, Deeney JT, Flatt PR, Gäbel J, Gromada J, Larsson O, Lindström P, Rhodes CJ, Rorsman P: PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic β cells. Science 271:813-815, 1996
18. Marks V, Samols E: Diazoxide therapy of intractable hypoglycemia. Ann NY Acad Sci 150:442-454, 1968
19. + fluxes and membrane potential in pancreatic B-cells. Biochem Pharmacol 31:1407-1415, 1982
20. Trube G, Rorsman P, Ohno-Shozaku T: Opposite effects of tolbutamide and diazoxide on the ATP-sensitive potassium channel. Lancet 2:493-499, 1986
21. 2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J Biol Chem 267:20713-20720, 1992
22. Renström E, Rorsman P: Intracellular tolbutamide stimulates calcium-dependent exocytosis in pancreatic B-cells (Abstract). Diabetologia 39 (Suppl. 1):A229, 1996
23. 2+ in pancreatic B cells, Eur J Phannacol 298:279-286, 1996
24. Hedeskov CJ: Mechanism of glucose-induced insulin secretion. Physiol Rev 60:442-509, 1980
25. Pipeleers D: The biosociology of pancreatic B cells. Diabetologia 30:277-291, 1987
26. Henquin JC: D-glucose inhibits potassium efflux from pancreatic islet cells. Nature 271:271-273, 1978
27. Neher E, Marty A: Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. Proc Natl Acad Sci USA 79:6712-6716, 1982
28. Lindau M, Neher E: Patch-clamp techniques for time-resolved capacitance measurements in single cells, Pflügers Arch, 411:137-146, 1988
29. Gillis KD: Techniques for membrane capacitance measurements. In SingleChannel Recording. Sakman B, Neher E, Eds. New York, Plenum, 1995, p. 155-198
30. Meissner HP, Henquin JC, Preissler M: Potassium dependence of the membrane potential of pancreatic B-cells. FEBS Lett 94:87-89, 1978
31. Garrino MG, Schmeer W, Nenquin M, Meissner HP, Henquin JC: Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabeiologia 28:697-703, 1985
32. + currents in pancreatic B-cells. Naunyn-Schmiedeberg's Arch Pharmacol 337:225-230, 1988
33. Fuhlendorff J, Carr R, Kofod H, Rorsman P: The mechanism of action of repaglinide differs to sulphonylureas in murine beta cells (Abstract). Pharmacol Res 31 (Suppl. 1):32, 1995
34. Gillis KD, Misler S: Single cell assay of exocytosis from pancreatic islet B cells. Pflügers Arch 420:121-123, 1992
35. 2+ entry. Pflügers Arch 424:195-197, 1993
36. Ämmälä C, Ashcroft FM, Rorsman P: Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 363:356-358, 1993
37. 2+-containing extracellular solutions. Pflügers Arch 430:593-595, 1995
38. 2+- and GTP-dependent exocytosis in mouse pancreatic β-cells Involves both common and distinct steps. J Physiol 496:255-264, 1996
39. Renström E, Ding WG, Bokvist K, Rorsman P: Neurotransmitter-induced inhibition of exocytosis in insulin-secreting β cells by activation of calcineurin. Neuron 17:513-522, 1996
40. + channel-independent glucose action. Endocrinology 136:3942-3948, 1995
41. Cunningham BA, Deeney JT, Bliss CR, Corkey BE, Tornheim K: Glucoseinduced oscillatory insulin secretion in perifused rat pancreatic islets and clonal β-cells (HIT). Am J Physiol 271:E702-E710, 1996
42. + channel independent mechanisms: role of phospholipase C. Am J Physiol 272:E671-E677, 1997
43. Joshi C, Fernandez JM: Capacitance measurements: an analysis of the phase detector technique used to study exocytosis or endocytosis. Biophys J 53:885-892, 1988
44. Gillis KD, Mossner R, Neher E: Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16:1209-1220, 1996